Global Diptheria Vaccine
Global Diptheria Vaccine

Diptheria Vaccine Comprehensive Study by Type (Daptacel, Infanrix, Kinrix, Pediarix, Pentacel, Quaracel), Disease Type (Diphtheria, Tetanus, Pertussis), Packaging Type (0.5 ML, 1 ML, 2 ML, Others), Age Group (Adult, Pediatric), End User (Hospitals, Clinics, Vaccination Centers) Players and Region - Global Market Outlook to 2026

Diptheria Vaccine Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Jan 2021 Edition 205 Pages 170 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Diptheria Vaccine Market Scope?
Diphtheria can be described as an infection which is caused by the bacterium Corynebacterium diphtheria. This disease can lead to severe problems such as inflammation of nerves, myocarditis, kidney problems, and bleeding problems, caused due to low levels of platelets. Diphtheria vaccine’s function is to block the expansion of Corynebacterium diphtheriae and is highly efficient in killing it. One of the biggest advantages of this vaccine is that it is free from side effects, as a result of this, it is very safe to be used in pregnant woman and low-immunity individuals. The growing incidence of diphtheria, tetanus, and pertussis coupled with rising worldwide governmental support for the vaccination programs is driving the growth of the global Diptheria vaccine market.

The Diptheria Vaccine market study is being classified by Type (Daptacel, Infanrix, Kinrix, Pediarix, Pentacel and Quaracel) and major geographies with country level break-up.

Research Analyst at AMA predicts that Players from European and United States will contribute to the maximum growth of Global Diptheria Vaccine market throughout the predicted period.

GlaxoSmithKline plc (United Kingdom), Sanofi Pasteur (France), Protein Sciences Corporation (United States), Novartis AG (Switzerland), Merck & Co., Inc. (United States), Pfizer Inc. (United States), Astellas Pharma Inc. (Japan), AstraZeneca (United Kingdom), Johnson & Johnson (United States) and Emergent Biosolution Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are AJ Vaccines (Denmark), Bionet-Asia (Thailand), Massbiologics (United States), KM biologics co., Ltd. (Japan), Panacea Biotec Ltd. (India) and Serum Institute of India Pvt. Ltd. (India).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Diptheria Vaccine market by Type, Application and Region.

On the basis of geography, the market of Diptheria Vaccine has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Influencers and their development strategies
On 22nd June 2020, Pfizer Inc has announced the initiation of four Phase 3 clinical trials within its current pipeline of investigational vaccines. With safety and tolerability of the investigational vaccine in infants and include a control group of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]).
On 26th December 2018, VAXELIS, a joint-partnership between Sanofi and MSD, known as Merck inside the United States and Canada. the company has announced that The U.S. Food and Drug Administration has approved VAXELIS(TM) (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate Meningococcal Protein Conjugate, and Hepatitis B Recombinant Vaccine) for use in children from 6 weeks through 4 years of age (prior to the 5th birthday).


Influencing Market Trend
  • Technological Advancement and Development in Vaccine Development

Market Drivers
  • Growth in Government and Non-Government Initiatives for Vaccine Development
  • Increasing in Awareness among People Regarding Diptheria Vaccine

Opportunities
  • Rising Investing in R&D activities by Various Vaccine Manufacturers, Growing Awareness, and Subsequent Demand for Diptheria Vaccine

Restraints
  • High Cost of Vaccine Development

Challenges
  • Inadequate access to Vaccines in Under Developed Countries


Key Target Audience
Diptheria Vaccine Manufacturers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Others

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.
Report Objectives / Segmentation Covered
By Type
  • Daptacel
  • Infanrix
  • Kinrix
  • Pediarix
  • Pentacel
  • Quaracel
By Disease Type
  • Diphtheria
  • Tetanus
  • Pertussis

By Packaging Type
  • 0.5 ML
  • 1 ML
  • 2 ML
  • Others

By Age Group
  • Adult
  • Pediatric

By End User
  • Hospitals
  • Clinics
  • Vaccination Centers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growth in Government and Non-Government Initiatives for Vaccine Development
      • 3.2.2. Increasing in Awareness among People Regarding Diptheria Vaccine
    • 3.3. Market Challenges
      • 3.3.1. Inadequate access to Vaccines in Under Developed Countries
    • 3.4. Market Trends
      • 3.4.1. Technological Advancement and Development in Vaccine Development
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Diptheria Vaccine, by Type, Disease Type, Packaging Type, Age Group, End User and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Diptheria Vaccine (Value)
      • 5.2.1. Global Diptheria Vaccine by: Type (Value)
        • 5.2.1.1. Daptacel
        • 5.2.1.2. Infanrix
        • 5.2.1.3. Kinrix
        • 5.2.1.4. Pediarix
        • 5.2.1.5. Pentacel
        • 5.2.1.6. Quaracel
      • 5.2.2. Global Diptheria Vaccine by: Disease Type (Value)
        • 5.2.2.1. Diphtheria
        • 5.2.2.2. Tetanus
        • 5.2.2.3. Pertussis
      • 5.2.3. Global Diptheria Vaccine by: Packaging Type (Value)
        • 5.2.3.1. 0.5 ML
        • 5.2.3.2. 1 ML
        • 5.2.3.3. 2 ML
        • 5.2.3.4. Others
      • 5.2.4. Global Diptheria Vaccine by: Age Group (Value)
        • 5.2.4.1. Adult
        • 5.2.4.2. Pediatric
      • 5.2.5. Global Diptheria Vaccine by: End User (Value)
        • 5.2.5.1. Hospitals
        • 5.2.5.2. Clinics
        • 5.2.5.3. Vaccination Centers
      • 5.2.6. Global Diptheria Vaccine Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Diptheria Vaccine (Volume)
      • 5.3.1. Global Diptheria Vaccine by: Type (Volume)
        • 5.3.1.1. Daptacel
        • 5.3.1.2. Infanrix
        • 5.3.1.3. Kinrix
        • 5.3.1.4. Pediarix
        • 5.3.1.5. Pentacel
        • 5.3.1.6. Quaracel
      • 5.3.2. Global Diptheria Vaccine by: Disease Type (Volume)
        • 5.3.2.1. Diphtheria
        • 5.3.2.2. Tetanus
        • 5.3.2.3. Pertussis
      • 5.3.3. Global Diptheria Vaccine by: Packaging Type (Volume)
        • 5.3.3.1. 0.5 ML
        • 5.3.3.2. 1 ML
        • 5.3.3.3. 2 ML
        • 5.3.3.4. Others
      • 5.3.4. Global Diptheria Vaccine by: Age Group (Volume)
        • 5.3.4.1. Adult
        • 5.3.4.2. Pediatric
      • 5.3.5. Global Diptheria Vaccine by: End User (Volume)
        • 5.3.5.1. Hospitals
        • 5.3.5.2. Clinics
        • 5.3.5.3. Vaccination Centers
      • 5.3.6. Global Diptheria Vaccine Region
        • 5.3.6.1. South America
          • 5.3.6.1.1. Brazil
          • 5.3.6.1.2. Argentina
          • 5.3.6.1.3. Rest of South America
        • 5.3.6.2. Asia Pacific
          • 5.3.6.2.1. China
          • 5.3.6.2.2. Japan
          • 5.3.6.2.3. India
          • 5.3.6.2.4. South Korea
          • 5.3.6.2.5. Taiwan
          • 5.3.6.2.6. Australia
          • 5.3.6.2.7. Rest of Asia-Pacific
        • 5.3.6.3. Europe
          • 5.3.6.3.1. Germany
          • 5.3.6.3.2. France
          • 5.3.6.3.3. Italy
          • 5.3.6.3.4. United Kingdom
          • 5.3.6.3.5. Netherlands
          • 5.3.6.3.6. Rest of Europe
        • 5.3.6.4. MEA
          • 5.3.6.4.1. Middle East
          • 5.3.6.4.2. Africa
        • 5.3.6.5. North America
          • 5.3.6.5.1. United States
          • 5.3.6.5.2. Canada
          • 5.3.6.5.3. Mexico
    • 5.4. Global Diptheria Vaccine (Price)
      • 5.4.1. Global Diptheria Vaccine by: Type (Price)
  • 6. Diptheria Vaccine: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. GlaxoSmithKline plc (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Sanofi Pasteur (France)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Protein Sciences Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Novartis AG (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Merck & Co., Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Pfizer Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Astellas Pharma Inc. (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. AstraZeneca (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Johnson & Johnson (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Emergent Biosolution Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Diptheria Vaccine Sale, by Type, Disease Type, Packaging Type, Age Group, End User and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Diptheria Vaccine (Value)
      • 7.2.1. Global Diptheria Vaccine by: Type (Value)
        • 7.2.1.1. Daptacel
        • 7.2.1.2. Infanrix
        • 7.2.1.3. Kinrix
        • 7.2.1.4. Pediarix
        • 7.2.1.5. Pentacel
        • 7.2.1.6. Quaracel
      • 7.2.2. Global Diptheria Vaccine by: Disease Type (Value)
        • 7.2.2.1. Diphtheria
        • 7.2.2.2. Tetanus
        • 7.2.2.3. Pertussis
      • 7.2.3. Global Diptheria Vaccine by: Packaging Type (Value)
        • 7.2.3.1. 0.5 ML
        • 7.2.3.2. 1 ML
        • 7.2.3.3. 2 ML
        • 7.2.3.4. Others
      • 7.2.4. Global Diptheria Vaccine by: Age Group (Value)
        • 7.2.4.1. Adult
        • 7.2.4.2. Pediatric
      • 7.2.5. Global Diptheria Vaccine by: End User (Value)
        • 7.2.5.1. Hospitals
        • 7.2.5.2. Clinics
        • 7.2.5.3. Vaccination Centers
      • 7.2.6. Global Diptheria Vaccine Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Diptheria Vaccine (Volume)
      • 7.3.1. Global Diptheria Vaccine by: Type (Volume)
        • 7.3.1.1. Daptacel
        • 7.3.1.2. Infanrix
        • 7.3.1.3. Kinrix
        • 7.3.1.4. Pediarix
        • 7.3.1.5. Pentacel
        • 7.3.1.6. Quaracel
      • 7.3.2. Global Diptheria Vaccine by: Disease Type (Volume)
        • 7.3.2.1. Diphtheria
        • 7.3.2.2. Tetanus
        • 7.3.2.3. Pertussis
      • 7.3.3. Global Diptheria Vaccine by: Packaging Type (Volume)
        • 7.3.3.1. 0.5 ML
        • 7.3.3.2. 1 ML
        • 7.3.3.3. 2 ML
        • 7.3.3.4. Others
      • 7.3.4. Global Diptheria Vaccine by: Age Group (Volume)
        • 7.3.4.1. Adult
        • 7.3.4.2. Pediatric
      • 7.3.5. Global Diptheria Vaccine by: End User (Volume)
        • 7.3.5.1. Hospitals
        • 7.3.5.2. Clinics
        • 7.3.5.3. Vaccination Centers
      • 7.3.6. Global Diptheria Vaccine Region
        • 7.3.6.1. South America
          • 7.3.6.1.1. Brazil
          • 7.3.6.1.2. Argentina
          • 7.3.6.1.3. Rest of South America
        • 7.3.6.2. Asia Pacific
          • 7.3.6.2.1. China
          • 7.3.6.2.2. Japan
          • 7.3.6.2.3. India
          • 7.3.6.2.4. South Korea
          • 7.3.6.2.5. Taiwan
          • 7.3.6.2.6. Australia
          • 7.3.6.2.7. Rest of Asia-Pacific
        • 7.3.6.3. Europe
          • 7.3.6.3.1. Germany
          • 7.3.6.3.2. France
          • 7.3.6.3.3. Italy
          • 7.3.6.3.4. United Kingdom
          • 7.3.6.3.5. Netherlands
          • 7.3.6.3.6. Rest of Europe
        • 7.3.6.4. MEA
          • 7.3.6.4.1. Middle East
          • 7.3.6.4.2. Africa
        • 7.3.6.5. North America
          • 7.3.6.5.1. United States
          • 7.3.6.5.2. Canada
          • 7.3.6.5.3. Mexico
    • 7.4. Global Diptheria Vaccine (Price)
      • 7.4.1. Global Diptheria Vaccine by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Diptheria Vaccine: by Type(USD Million)
  • Table 2. Diptheria Vaccine Daptacel , by Region USD Million (2015-2020)
  • Table 3. Diptheria Vaccine Infanrix , by Region USD Million (2015-2020)
  • Table 4. Diptheria Vaccine Kinrix , by Region USD Million (2015-2020)
  • Table 5. Diptheria Vaccine Pediarix , by Region USD Million (2015-2020)
  • Table 6. Diptheria Vaccine Pentacel , by Region USD Million (2015-2020)
  • Table 7. Diptheria Vaccine Quaracel , by Region USD Million (2015-2020)
  • Table 8. Diptheria Vaccine: by Disease Type(USD Million)
  • Table 9. Diptheria Vaccine Diphtheria , by Region USD Million (2015-2020)
  • Table 10. Diptheria Vaccine Tetanus , by Region USD Million (2015-2020)
  • Table 11. Diptheria Vaccine Pertussis , by Region USD Million (2015-2020)
  • Table 12. Diptheria Vaccine: by Packaging Type(USD Million)
  • Table 13. Diptheria Vaccine 0.5 ML , by Region USD Million (2015-2020)
  • Table 14. Diptheria Vaccine 1 ML , by Region USD Million (2015-2020)
  • Table 15. Diptheria Vaccine 2 ML , by Region USD Million (2015-2020)
  • Table 16. Diptheria Vaccine Others , by Region USD Million (2015-2020)
  • Table 17. Diptheria Vaccine: by Age Group(USD Million)
  • Table 18. Diptheria Vaccine Adult , by Region USD Million (2015-2020)
  • Table 19. Diptheria Vaccine Pediatric , by Region USD Million (2015-2020)
  • Table 20. Diptheria Vaccine: by End User(USD Million)
  • Table 21. Diptheria Vaccine Hospitals , by Region USD Million (2015-2020)
  • Table 22. Diptheria Vaccine Clinics , by Region USD Million (2015-2020)
  • Table 23. Diptheria Vaccine Vaccination Centers , by Region USD Million (2015-2020)
  • Table 24. South America Diptheria Vaccine, by Country USD Million (2015-2020)
  • Table 25. South America Diptheria Vaccine, by Type USD Million (2015-2020)
  • Table 26. South America Diptheria Vaccine, by Disease Type USD Million (2015-2020)
  • Table 27. South America Diptheria Vaccine, by Packaging Type USD Million (2015-2020)
  • Table 28. South America Diptheria Vaccine, by Age Group USD Million (2015-2020)
  • Table 29. South America Diptheria Vaccine, by End User USD Million (2015-2020)
  • Table 30. Brazil Diptheria Vaccine, by Type USD Million (2015-2020)
  • Table 31. Brazil Diptheria Vaccine, by Disease Type USD Million (2015-2020)
  • Table 32. Brazil Diptheria Vaccine, by Packaging Type USD Million (2015-2020)
  • Table 33. Brazil Diptheria Vaccine, by Age Group USD Million (2015-2020)
  • Table 34. Brazil Diptheria Vaccine, by End User USD Million (2015-2020)
  • Table 35. Argentina Diptheria Vaccine, by Type USD Million (2015-2020)
  • Table 36. Argentina Diptheria Vaccine, by Disease Type USD Million (2015-2020)
  • Table 37. Argentina Diptheria Vaccine, by Packaging Type USD Million (2015-2020)
  • Table 38. Argentina Diptheria Vaccine, by Age Group USD Million (2015-2020)
  • Table 39. Argentina Diptheria Vaccine, by End User USD Million (2015-2020)
  • Table 40. Rest of South America Diptheria Vaccine, by Type USD Million (2015-2020)
  • Table 41. Rest of South America Diptheria Vaccine, by Disease Type USD Million (2015-2020)
  • Table 42. Rest of South America Diptheria Vaccine, by Packaging Type USD Million (2015-2020)
  • Table 43. Rest of South America Diptheria Vaccine, by Age Group USD Million (2015-2020)
  • Table 44. Rest of South America Diptheria Vaccine, by End User USD Million (2015-2020)
  • Table 45. Asia Pacific Diptheria Vaccine, by Country USD Million (2015-2020)
  • Table 46. Asia Pacific Diptheria Vaccine, by Type USD Million (2015-2020)
  • Table 47. Asia Pacific Diptheria Vaccine, by Disease Type USD Million (2015-2020)
  • Table 48. Asia Pacific Diptheria Vaccine, by Packaging Type USD Million (2015-2020)
  • Table 49. Asia Pacific Diptheria Vaccine, by Age Group USD Million (2015-2020)
  • Table 50. Asia Pacific Diptheria Vaccine, by End User USD Million (2015-2020)
  • Table 51. China Diptheria Vaccine, by Type USD Million (2015-2020)
  • Table 52. China Diptheria Vaccine, by Disease Type USD Million (2015-2020)
  • Table 53. China Diptheria Vaccine, by Packaging Type USD Million (2015-2020)
  • Table 54. China Diptheria Vaccine, by Age Group USD Million (2015-2020)
  • Table 55. China Diptheria Vaccine, by End User USD Million (2015-2020)
  • Table 56. Japan Diptheria Vaccine, by Type USD Million (2015-2020)
  • Table 57. Japan Diptheria Vaccine, by Disease Type USD Million (2015-2020)
  • Table 58. Japan Diptheria Vaccine, by Packaging Type USD Million (2015-2020)
  • Table 59. Japan Diptheria Vaccine, by Age Group USD Million (2015-2020)
  • Table 60. Japan Diptheria Vaccine, by End User USD Million (2015-2020)
  • Table 61. India Diptheria Vaccine, by Type USD Million (2015-2020)
  • Table 62. India Diptheria Vaccine, by Disease Type USD Million (2015-2020)
  • Table 63. India Diptheria Vaccine, by Packaging Type USD Million (2015-2020)
  • Table 64. India Diptheria Vaccine, by Age Group USD Million (2015-2020)
  • Table 65. India Diptheria Vaccine, by End User USD Million (2015-2020)
  • Table 66. South Korea Diptheria Vaccine, by Type USD Million (2015-2020)
  • Table 67. South Korea Diptheria Vaccine, by Disease Type USD Million (2015-2020)
  • Table 68. South Korea Diptheria Vaccine, by Packaging Type USD Million (2015-2020)
  • Table 69. South Korea Diptheria Vaccine, by Age Group USD Million (2015-2020)
  • Table 70. South Korea Diptheria Vaccine, by End User USD Million (2015-2020)
  • Table 71. Taiwan Diptheria Vaccine, by Type USD Million (2015-2020)
  • Table 72. Taiwan Diptheria Vaccine, by Disease Type USD Million (2015-2020)
  • Table 73. Taiwan Diptheria Vaccine, by Packaging Type USD Million (2015-2020)
  • Table 74. Taiwan Diptheria Vaccine, by Age Group USD Million (2015-2020)
  • Table 75. Taiwan Diptheria Vaccine, by End User USD Million (2015-2020)
  • Table 76. Australia Diptheria Vaccine, by Type USD Million (2015-2020)
  • Table 77. Australia Diptheria Vaccine, by Disease Type USD Million (2015-2020)
  • Table 78. Australia Diptheria Vaccine, by Packaging Type USD Million (2015-2020)
  • Table 79. Australia Diptheria Vaccine, by Age Group USD Million (2015-2020)
  • Table 80. Australia Diptheria Vaccine, by End User USD Million (2015-2020)
  • Table 81. Rest of Asia-Pacific Diptheria Vaccine, by Type USD Million (2015-2020)
  • Table 82. Rest of Asia-Pacific Diptheria Vaccine, by Disease Type USD Million (2015-2020)
  • Table 83. Rest of Asia-Pacific Diptheria Vaccine, by Packaging Type USD Million (2015-2020)
  • Table 84. Rest of Asia-Pacific Diptheria Vaccine, by Age Group USD Million (2015-2020)
  • Table 85. Rest of Asia-Pacific Diptheria Vaccine, by End User USD Million (2015-2020)
  • Table 86. Europe Diptheria Vaccine, by Country USD Million (2015-2020)
  • Table 87. Europe Diptheria Vaccine, by Type USD Million (2015-2020)
  • Table 88. Europe Diptheria Vaccine, by Disease Type USD Million (2015-2020)
  • Table 89. Europe Diptheria Vaccine, by Packaging Type USD Million (2015-2020)
  • Table 90. Europe Diptheria Vaccine, by Age Group USD Million (2015-2020)
  • Table 91. Europe Diptheria Vaccine, by End User USD Million (2015-2020)
  • Table 92. Germany Diptheria Vaccine, by Type USD Million (2015-2020)
  • Table 93. Germany Diptheria Vaccine, by Disease Type USD Million (2015-2020)
  • Table 94. Germany Diptheria Vaccine, by Packaging Type USD Million (2015-2020)
  • Table 95. Germany Diptheria Vaccine, by Age Group USD Million (2015-2020)
  • Table 96. Germany Diptheria Vaccine, by End User USD Million (2015-2020)
  • Table 97. France Diptheria Vaccine, by Type USD Million (2015-2020)
  • Table 98. France Diptheria Vaccine, by Disease Type USD Million (2015-2020)
  • Table 99. France Diptheria Vaccine, by Packaging Type USD Million (2015-2020)
  • Table 100. France Diptheria Vaccine, by Age Group USD Million (2015-2020)
  • Table 101. France Diptheria Vaccine, by End User USD Million (2015-2020)
  • Table 102. Italy Diptheria Vaccine, by Type USD Million (2015-2020)
  • Table 103. Italy Diptheria Vaccine, by Disease Type USD Million (2015-2020)
  • Table 104. Italy Diptheria Vaccine, by Packaging Type USD Million (2015-2020)
  • Table 105. Italy Diptheria Vaccine, by Age Group USD Million (2015-2020)
  • Table 106. Italy Diptheria Vaccine, by End User USD Million (2015-2020)
  • Table 107. United Kingdom Diptheria Vaccine, by Type USD Million (2015-2020)
  • Table 108. United Kingdom Diptheria Vaccine, by Disease Type USD Million (2015-2020)
  • Table 109. United Kingdom Diptheria Vaccine, by Packaging Type USD Million (2015-2020)
  • Table 110. United Kingdom Diptheria Vaccine, by Age Group USD Million (2015-2020)
  • Table 111. United Kingdom Diptheria Vaccine, by End User USD Million (2015-2020)
  • Table 112. Netherlands Diptheria Vaccine, by Type USD Million (2015-2020)
  • Table 113. Netherlands Diptheria Vaccine, by Disease Type USD Million (2015-2020)
  • Table 114. Netherlands Diptheria Vaccine, by Packaging Type USD Million (2015-2020)
  • Table 115. Netherlands Diptheria Vaccine, by Age Group USD Million (2015-2020)
  • Table 116. Netherlands Diptheria Vaccine, by End User USD Million (2015-2020)
  • Table 117. Rest of Europe Diptheria Vaccine, by Type USD Million (2015-2020)
  • Table 118. Rest of Europe Diptheria Vaccine, by Disease Type USD Million (2015-2020)
  • Table 119. Rest of Europe Diptheria Vaccine, by Packaging Type USD Million (2015-2020)
  • Table 120. Rest of Europe Diptheria Vaccine, by Age Group USD Million (2015-2020)
  • Table 121. Rest of Europe Diptheria Vaccine, by End User USD Million (2015-2020)
  • Table 122. MEA Diptheria Vaccine, by Country USD Million (2015-2020)
  • Table 123. MEA Diptheria Vaccine, by Type USD Million (2015-2020)
  • Table 124. MEA Diptheria Vaccine, by Disease Type USD Million (2015-2020)
  • Table 125. MEA Diptheria Vaccine, by Packaging Type USD Million (2015-2020)
  • Table 126. MEA Diptheria Vaccine, by Age Group USD Million (2015-2020)
  • Table 127. MEA Diptheria Vaccine, by End User USD Million (2015-2020)
  • Table 128. Middle East Diptheria Vaccine, by Type USD Million (2015-2020)
  • Table 129. Middle East Diptheria Vaccine, by Disease Type USD Million (2015-2020)
  • Table 130. Middle East Diptheria Vaccine, by Packaging Type USD Million (2015-2020)
  • Table 131. Middle East Diptheria Vaccine, by Age Group USD Million (2015-2020)
  • Table 132. Middle East Diptheria Vaccine, by End User USD Million (2015-2020)
  • Table 133. Africa Diptheria Vaccine, by Type USD Million (2015-2020)
  • Table 134. Africa Diptheria Vaccine, by Disease Type USD Million (2015-2020)
  • Table 135. Africa Diptheria Vaccine, by Packaging Type USD Million (2015-2020)
  • Table 136. Africa Diptheria Vaccine, by Age Group USD Million (2015-2020)
  • Table 137. Africa Diptheria Vaccine, by End User USD Million (2015-2020)
  • Table 138. North America Diptheria Vaccine, by Country USD Million (2015-2020)
  • Table 139. North America Diptheria Vaccine, by Type USD Million (2015-2020)
  • Table 140. North America Diptheria Vaccine, by Disease Type USD Million (2015-2020)
  • Table 141. North America Diptheria Vaccine, by Packaging Type USD Million (2015-2020)
  • Table 142. North America Diptheria Vaccine, by Age Group USD Million (2015-2020)
  • Table 143. North America Diptheria Vaccine, by End User USD Million (2015-2020)
  • Table 144. United States Diptheria Vaccine, by Type USD Million (2015-2020)
  • Table 145. United States Diptheria Vaccine, by Disease Type USD Million (2015-2020)
  • Table 146. United States Diptheria Vaccine, by Packaging Type USD Million (2015-2020)
  • Table 147. United States Diptheria Vaccine, by Age Group USD Million (2015-2020)
  • Table 148. United States Diptheria Vaccine, by End User USD Million (2015-2020)
  • Table 149. Canada Diptheria Vaccine, by Type USD Million (2015-2020)
  • Table 150. Canada Diptheria Vaccine, by Disease Type USD Million (2015-2020)
  • Table 151. Canada Diptheria Vaccine, by Packaging Type USD Million (2015-2020)
  • Table 152. Canada Diptheria Vaccine, by Age Group USD Million (2015-2020)
  • Table 153. Canada Diptheria Vaccine, by End User USD Million (2015-2020)
  • Table 154. Mexico Diptheria Vaccine, by Type USD Million (2015-2020)
  • Table 155. Mexico Diptheria Vaccine, by Disease Type USD Million (2015-2020)
  • Table 156. Mexico Diptheria Vaccine, by Packaging Type USD Million (2015-2020)
  • Table 157. Mexico Diptheria Vaccine, by Age Group USD Million (2015-2020)
  • Table 158. Mexico Diptheria Vaccine, by End User USD Million (2015-2020)
  • Table 159. Diptheria Vaccine Sales: by Type(Tonne)
  • Table 160. Diptheria Vaccine Sales Daptacel , by Region Tonne (2015-2020)
  • Table 161. Diptheria Vaccine Sales Infanrix , by Region Tonne (2015-2020)
  • Table 162. Diptheria Vaccine Sales Kinrix , by Region Tonne (2015-2020)
  • Table 163. Diptheria Vaccine Sales Pediarix , by Region Tonne (2015-2020)
  • Table 164. Diptheria Vaccine Sales Pentacel , by Region Tonne (2015-2020)
  • Table 165. Diptheria Vaccine Sales Quaracel , by Region Tonne (2015-2020)
  • Table 166. Diptheria Vaccine Sales: by Disease Type(Tonne)
  • Table 167. Diptheria Vaccine Sales Diphtheria , by Region Tonne (2015-2020)
  • Table 168. Diptheria Vaccine Sales Tetanus , by Region Tonne (2015-2020)
  • Table 169. Diptheria Vaccine Sales Pertussis , by Region Tonne (2015-2020)
  • Table 170. Diptheria Vaccine Sales: by Packaging Type(Tonne)
  • Table 171. Diptheria Vaccine Sales 0.5 ML , by Region Tonne (2015-2020)
  • Table 172. Diptheria Vaccine Sales 1 ML , by Region Tonne (2015-2020)
  • Table 173. Diptheria Vaccine Sales 2 ML , by Region Tonne (2015-2020)
  • Table 174. Diptheria Vaccine Sales Others , by Region Tonne (2015-2020)
  • Table 175. Diptheria Vaccine Sales: by Age Group(Tonne)
  • Table 176. Diptheria Vaccine Sales Adult , by Region Tonne (2015-2020)
  • Table 177. Diptheria Vaccine Sales Pediatric , by Region Tonne (2015-2020)
  • Table 178. Diptheria Vaccine Sales: by End User(Tonne)
  • Table 179. Diptheria Vaccine Sales Hospitals , by Region Tonne (2015-2020)
  • Table 180. Diptheria Vaccine Sales Clinics , by Region Tonne (2015-2020)
  • Table 181. Diptheria Vaccine Sales Vaccination Centers , by Region Tonne (2015-2020)
  • Table 182. South America Diptheria Vaccine Sales, by Country Tonne (2015-2020)
  • Table 183. South America Diptheria Vaccine Sales, by Type Tonne (2015-2020)
  • Table 184. South America Diptheria Vaccine Sales, by Disease Type Tonne (2015-2020)
  • Table 185. South America Diptheria Vaccine Sales, by Packaging Type Tonne (2015-2020)
  • Table 186. South America Diptheria Vaccine Sales, by Age Group Tonne (2015-2020)
  • Table 187. South America Diptheria Vaccine Sales, by End User Tonne (2015-2020)
  • Table 188. Brazil Diptheria Vaccine Sales, by Type Tonne (2015-2020)
  • Table 189. Brazil Diptheria Vaccine Sales, by Disease Type Tonne (2015-2020)
  • Table 190. Brazil Diptheria Vaccine Sales, by Packaging Type Tonne (2015-2020)
  • Table 191. Brazil Diptheria Vaccine Sales, by Age Group Tonne (2015-2020)
  • Table 192. Brazil Diptheria Vaccine Sales, by End User Tonne (2015-2020)
  • Table 193. Argentina Diptheria Vaccine Sales, by Type Tonne (2015-2020)
  • Table 194. Argentina Diptheria Vaccine Sales, by Disease Type Tonne (2015-2020)
  • Table 195. Argentina Diptheria Vaccine Sales, by Packaging Type Tonne (2015-2020)
  • Table 196. Argentina Diptheria Vaccine Sales, by Age Group Tonne (2015-2020)
  • Table 197. Argentina Diptheria Vaccine Sales, by End User Tonne (2015-2020)
  • Table 198. Rest of South America Diptheria Vaccine Sales, by Type Tonne (2015-2020)
  • Table 199. Rest of South America Diptheria Vaccine Sales, by Disease Type Tonne (2015-2020)
  • Table 200. Rest of South America Diptheria Vaccine Sales, by Packaging Type Tonne (2015-2020)
  • Table 201. Rest of South America Diptheria Vaccine Sales, by Age Group Tonne (2015-2020)
  • Table 202. Rest of South America Diptheria Vaccine Sales, by End User Tonne (2015-2020)
  • Table 203. Asia Pacific Diptheria Vaccine Sales, by Country Tonne (2015-2020)
  • Table 204. Asia Pacific Diptheria Vaccine Sales, by Type Tonne (2015-2020)
  • Table 205. Asia Pacific Diptheria Vaccine Sales, by Disease Type Tonne (2015-2020)
  • Table 206. Asia Pacific Diptheria Vaccine Sales, by Packaging Type Tonne (2015-2020)
  • Table 207. Asia Pacific Diptheria Vaccine Sales, by Age Group Tonne (2015-2020)
  • Table 208. Asia Pacific Diptheria Vaccine Sales, by End User Tonne (2015-2020)
  • Table 209. China Diptheria Vaccine Sales, by Type Tonne (2015-2020)
  • Table 210. China Diptheria Vaccine Sales, by Disease Type Tonne (2015-2020)
  • Table 211. China Diptheria Vaccine Sales, by Packaging Type Tonne (2015-2020)
  • Table 212. China Diptheria Vaccine Sales, by Age Group Tonne (2015-2020)
  • Table 213. China Diptheria Vaccine Sales, by End User Tonne (2015-2020)
  • Table 214. Japan Diptheria Vaccine Sales, by Type Tonne (2015-2020)
  • Table 215. Japan Diptheria Vaccine Sales, by Disease Type Tonne (2015-2020)
  • Table 216. Japan Diptheria Vaccine Sales, by Packaging Type Tonne (2015-2020)
  • Table 217. Japan Diptheria Vaccine Sales, by Age Group Tonne (2015-2020)
  • Table 218. Japan Diptheria Vaccine Sales, by End User Tonne (2015-2020)
  • Table 219. India Diptheria Vaccine Sales, by Type Tonne (2015-2020)
  • Table 220. India Diptheria Vaccine Sales, by Disease Type Tonne (2015-2020)
  • Table 221. India Diptheria Vaccine Sales, by Packaging Type Tonne (2015-2020)
  • Table 222. India Diptheria Vaccine Sales, by Age Group Tonne (2015-2020)
  • Table 223. India Diptheria Vaccine Sales, by End User Tonne (2015-2020)
  • Table 224. South Korea Diptheria Vaccine Sales, by Type Tonne (2015-2020)
  • Table 225. South Korea Diptheria Vaccine Sales, by Disease Type Tonne (2015-2020)
  • Table 226. South Korea Diptheria Vaccine Sales, by Packaging Type Tonne (2015-2020)
  • Table 227. South Korea Diptheria Vaccine Sales, by Age Group Tonne (2015-2020)
  • Table 228. South Korea Diptheria Vaccine Sales, by End User Tonne (2015-2020)
  • Table 229. Taiwan Diptheria Vaccine Sales, by Type Tonne (2015-2020)
  • Table 230. Taiwan Diptheria Vaccine Sales, by Disease Type Tonne (2015-2020)
  • Table 231. Taiwan Diptheria Vaccine Sales, by Packaging Type Tonne (2015-2020)
  • Table 232. Taiwan Diptheria Vaccine Sales, by Age Group Tonne (2015-2020)
  • Table 233. Taiwan Diptheria Vaccine Sales, by End User Tonne (2015-2020)
  • Table 234. Australia Diptheria Vaccine Sales, by Type Tonne (2015-2020)
  • Table 235. Australia Diptheria Vaccine Sales, by Disease Type Tonne (2015-2020)
  • Table 236. Australia Diptheria Vaccine Sales, by Packaging Type Tonne (2015-2020)
  • Table 237. Australia Diptheria Vaccine Sales, by Age Group Tonne (2015-2020)
  • Table 238. Australia Diptheria Vaccine Sales, by End User Tonne (2015-2020)
  • Table 239. Rest of Asia-Pacific Diptheria Vaccine Sales, by Type Tonne (2015-2020)
  • Table 240. Rest of Asia-Pacific Diptheria Vaccine Sales, by Disease Type Tonne (2015-2020)
  • Table 241. Rest of Asia-Pacific Diptheria Vaccine Sales, by Packaging Type Tonne (2015-2020)
  • Table 242. Rest of Asia-Pacific Diptheria Vaccine Sales, by Age Group Tonne (2015-2020)
  • Table 243. Rest of Asia-Pacific Diptheria Vaccine Sales, by End User Tonne (2015-2020)
  • Table 244. Europe Diptheria Vaccine Sales, by Country Tonne (2015-2020)
  • Table 245. Europe Diptheria Vaccine Sales, by Type Tonne (2015-2020)
  • Table 246. Europe Diptheria Vaccine Sales, by Disease Type Tonne (2015-2020)
  • Table 247. Europe Diptheria Vaccine Sales, by Packaging Type Tonne (2015-2020)
  • Table 248. Europe Diptheria Vaccine Sales, by Age Group Tonne (2015-2020)
  • Table 249. Europe Diptheria Vaccine Sales, by End User Tonne (2015-2020)
  • Table 250. Germany Diptheria Vaccine Sales, by Type Tonne (2015-2020)
  • Table 251. Germany Diptheria Vaccine Sales, by Disease Type Tonne (2015-2020)
  • Table 252. Germany Diptheria Vaccine Sales, by Packaging Type Tonne (2015-2020)
  • Table 253. Germany Diptheria Vaccine Sales, by Age Group Tonne (2015-2020)
  • Table 254. Germany Diptheria Vaccine Sales, by End User Tonne (2015-2020)
  • Table 255. France Diptheria Vaccine Sales, by Type Tonne (2015-2020)
  • Table 256. France Diptheria Vaccine Sales, by Disease Type Tonne (2015-2020)
  • Table 257. France Diptheria Vaccine Sales, by Packaging Type Tonne (2015-2020)
  • Table 258. France Diptheria Vaccine Sales, by Age Group Tonne (2015-2020)
  • Table 259. France Diptheria Vaccine Sales, by End User Tonne (2015-2020)
  • Table 260. Italy Diptheria Vaccine Sales, by Type Tonne (2015-2020)
  • Table 261. Italy Diptheria Vaccine Sales, by Disease Type Tonne (2015-2020)
  • Table 262. Italy Diptheria Vaccine Sales, by Packaging Type Tonne (2015-2020)
  • Table 263. Italy Diptheria Vaccine Sales, by Age Group Tonne (2015-2020)
  • Table 264. Italy Diptheria Vaccine Sales, by End User Tonne (2015-2020)
  • Table 265. United Kingdom Diptheria Vaccine Sales, by Type Tonne (2015-2020)
  • Table 266. United Kingdom Diptheria Vaccine Sales, by Disease Type Tonne (2015-2020)
  • Table 267. United Kingdom Diptheria Vaccine Sales, by Packaging Type Tonne (2015-2020)
  • Table 268. United Kingdom Diptheria Vaccine Sales, by Age Group Tonne (2015-2020)
  • Table 269. United Kingdom Diptheria Vaccine Sales, by End User Tonne (2015-2020)
  • Table 270. Netherlands Diptheria Vaccine Sales, by Type Tonne (2015-2020)
  • Table 271. Netherlands Diptheria Vaccine Sales, by Disease Type Tonne (2015-2020)
  • Table 272. Netherlands Diptheria Vaccine Sales, by Packaging Type Tonne (2015-2020)
  • Table 273. Netherlands Diptheria Vaccine Sales, by Age Group Tonne (2015-2020)
  • Table 274. Netherlands Diptheria Vaccine Sales, by End User Tonne (2015-2020)
  • Table 275. Rest of Europe Diptheria Vaccine Sales, by Type Tonne (2015-2020)
  • Table 276. Rest of Europe Diptheria Vaccine Sales, by Disease Type Tonne (2015-2020)
  • Table 277. Rest of Europe Diptheria Vaccine Sales, by Packaging Type Tonne (2015-2020)
  • Table 278. Rest of Europe Diptheria Vaccine Sales, by Age Group Tonne (2015-2020)
  • Table 279. Rest of Europe Diptheria Vaccine Sales, by End User Tonne (2015-2020)
  • Table 280. MEA Diptheria Vaccine Sales, by Country Tonne (2015-2020)
  • Table 281. MEA Diptheria Vaccine Sales, by Type Tonne (2015-2020)
  • Table 282. MEA Diptheria Vaccine Sales, by Disease Type Tonne (2015-2020)
  • Table 283. MEA Diptheria Vaccine Sales, by Packaging Type Tonne (2015-2020)
  • Table 284. MEA Diptheria Vaccine Sales, by Age Group Tonne (2015-2020)
  • Table 285. MEA Diptheria Vaccine Sales, by End User Tonne (2015-2020)
  • Table 286. Middle East Diptheria Vaccine Sales, by Type Tonne (2015-2020)
  • Table 287. Middle East Diptheria Vaccine Sales, by Disease Type Tonne (2015-2020)
  • Table 288. Middle East Diptheria Vaccine Sales, by Packaging Type Tonne (2015-2020)
  • Table 289. Middle East Diptheria Vaccine Sales, by Age Group Tonne (2015-2020)
  • Table 290. Middle East Diptheria Vaccine Sales, by End User Tonne (2015-2020)
  • Table 291. Africa Diptheria Vaccine Sales, by Type Tonne (2015-2020)
  • Table 292. Africa Diptheria Vaccine Sales, by Disease Type Tonne (2015-2020)
  • Table 293. Africa Diptheria Vaccine Sales, by Packaging Type Tonne (2015-2020)
  • Table 294. Africa Diptheria Vaccine Sales, by Age Group Tonne (2015-2020)
  • Table 295. Africa Diptheria Vaccine Sales, by End User Tonne (2015-2020)
  • Table 296. North America Diptheria Vaccine Sales, by Country Tonne (2015-2020)
  • Table 297. North America Diptheria Vaccine Sales, by Type Tonne (2015-2020)
  • Table 298. North America Diptheria Vaccine Sales, by Disease Type Tonne (2015-2020)
  • Table 299. North America Diptheria Vaccine Sales, by Packaging Type Tonne (2015-2020)
  • Table 300. North America Diptheria Vaccine Sales, by Age Group Tonne (2015-2020)
  • Table 301. North America Diptheria Vaccine Sales, by End User Tonne (2015-2020)
  • Table 302. United States Diptheria Vaccine Sales, by Type Tonne (2015-2020)
  • Table 303. United States Diptheria Vaccine Sales, by Disease Type Tonne (2015-2020)
  • Table 304. United States Diptheria Vaccine Sales, by Packaging Type Tonne (2015-2020)
  • Table 305. United States Diptheria Vaccine Sales, by Age Group Tonne (2015-2020)
  • Table 306. United States Diptheria Vaccine Sales, by End User Tonne (2015-2020)
  • Table 307. Canada Diptheria Vaccine Sales, by Type Tonne (2015-2020)
  • Table 308. Canada Diptheria Vaccine Sales, by Disease Type Tonne (2015-2020)
  • Table 309. Canada Diptheria Vaccine Sales, by Packaging Type Tonne (2015-2020)
  • Table 310. Canada Diptheria Vaccine Sales, by Age Group Tonne (2015-2020)
  • Table 311. Canada Diptheria Vaccine Sales, by End User Tonne (2015-2020)
  • Table 312. Mexico Diptheria Vaccine Sales, by Type Tonne (2015-2020)
  • Table 313. Mexico Diptheria Vaccine Sales, by Disease Type Tonne (2015-2020)
  • Table 314. Mexico Diptheria Vaccine Sales, by Packaging Type Tonne (2015-2020)
  • Table 315. Mexico Diptheria Vaccine Sales, by Age Group Tonne (2015-2020)
  • Table 316. Mexico Diptheria Vaccine Sales, by End User Tonne (2015-2020)
  • Table 317. Diptheria Vaccine: by Type(USD/Units)
  • Table 318. Company Basic Information, Sales Area and Its Competitors
  • Table 319. Company Basic Information, Sales Area and Its Competitors
  • Table 320. Company Basic Information, Sales Area and Its Competitors
  • Table 321. Company Basic Information, Sales Area and Its Competitors
  • Table 322. Company Basic Information, Sales Area and Its Competitors
  • Table 323. Company Basic Information, Sales Area and Its Competitors
  • Table 324. Company Basic Information, Sales Area and Its Competitors
  • Table 325. Company Basic Information, Sales Area and Its Competitors
  • Table 326. Company Basic Information, Sales Area and Its Competitors
  • Table 327. Company Basic Information, Sales Area and Its Competitors
  • Table 328. Diptheria Vaccine: by Type(USD Million)
  • Table 329. Diptheria Vaccine Daptacel , by Region USD Million (2021-2026)
  • Table 330. Diptheria Vaccine Infanrix , by Region USD Million (2021-2026)
  • Table 331. Diptheria Vaccine Kinrix , by Region USD Million (2021-2026)
  • Table 332. Diptheria Vaccine Pediarix , by Region USD Million (2021-2026)
  • Table 333. Diptheria Vaccine Pentacel , by Region USD Million (2021-2026)
  • Table 334. Diptheria Vaccine Quaracel , by Region USD Million (2021-2026)
  • Table 335. Diptheria Vaccine: by Disease Type(USD Million)
  • Table 336. Diptheria Vaccine Diphtheria , by Region USD Million (2021-2026)
  • Table 337. Diptheria Vaccine Tetanus , by Region USD Million (2021-2026)
  • Table 338. Diptheria Vaccine Pertussis , by Region USD Million (2021-2026)
  • Table 339. Diptheria Vaccine: by Packaging Type(USD Million)
  • Table 340. Diptheria Vaccine 0.5 ML , by Region USD Million (2021-2026)
  • Table 341. Diptheria Vaccine 1 ML , by Region USD Million (2021-2026)
  • Table 342. Diptheria Vaccine 2 ML , by Region USD Million (2021-2026)
  • Table 343. Diptheria Vaccine Others , by Region USD Million (2021-2026)
  • Table 344. Diptheria Vaccine: by Age Group(USD Million)
  • Table 345. Diptheria Vaccine Adult , by Region USD Million (2021-2026)
  • Table 346. Diptheria Vaccine Pediatric , by Region USD Million (2021-2026)
  • Table 347. Diptheria Vaccine: by End User(USD Million)
  • Table 348. Diptheria Vaccine Hospitals , by Region USD Million (2021-2026)
  • Table 349. Diptheria Vaccine Clinics , by Region USD Million (2021-2026)
  • Table 350. Diptheria Vaccine Vaccination Centers , by Region USD Million (2021-2026)
  • Table 351. South America Diptheria Vaccine, by Country USD Million (2021-2026)
  • Table 352. South America Diptheria Vaccine, by Type USD Million (2021-2026)
  • Table 353. South America Diptheria Vaccine, by Disease Type USD Million (2021-2026)
  • Table 354. South America Diptheria Vaccine, by Packaging Type USD Million (2021-2026)
  • Table 355. South America Diptheria Vaccine, by Age Group USD Million (2021-2026)
  • Table 356. South America Diptheria Vaccine, by End User USD Million (2021-2026)
  • Table 357. Brazil Diptheria Vaccine, by Type USD Million (2021-2026)
  • Table 358. Brazil Diptheria Vaccine, by Disease Type USD Million (2021-2026)
  • Table 359. Brazil Diptheria Vaccine, by Packaging Type USD Million (2021-2026)
  • Table 360. Brazil Diptheria Vaccine, by Age Group USD Million (2021-2026)
  • Table 361. Brazil Diptheria Vaccine, by End User USD Million (2021-2026)
  • Table 362. Argentina Diptheria Vaccine, by Type USD Million (2021-2026)
  • Table 363. Argentina Diptheria Vaccine, by Disease Type USD Million (2021-2026)
  • Table 364. Argentina Diptheria Vaccine, by Packaging Type USD Million (2021-2026)
  • Table 365. Argentina Diptheria Vaccine, by Age Group USD Million (2021-2026)
  • Table 366. Argentina Diptheria Vaccine, by End User USD Million (2021-2026)
  • Table 367. Rest of South America Diptheria Vaccine, by Type USD Million (2021-2026)
  • Table 368. Rest of South America Diptheria Vaccine, by Disease Type USD Million (2021-2026)
  • Table 369. Rest of South America Diptheria Vaccine, by Packaging Type USD Million (2021-2026)
  • Table 370. Rest of South America Diptheria Vaccine, by Age Group USD Million (2021-2026)
  • Table 371. Rest of South America Diptheria Vaccine, by End User USD Million (2021-2026)
  • Table 372. Asia Pacific Diptheria Vaccine, by Country USD Million (2021-2026)
  • Table 373. Asia Pacific Diptheria Vaccine, by Type USD Million (2021-2026)
  • Table 374. Asia Pacific Diptheria Vaccine, by Disease Type USD Million (2021-2026)
  • Table 375. Asia Pacific Diptheria Vaccine, by Packaging Type USD Million (2021-2026)
  • Table 376. Asia Pacific Diptheria Vaccine, by Age Group USD Million (2021-2026)
  • Table 377. Asia Pacific Diptheria Vaccine, by End User USD Million (2021-2026)
  • Table 378. China Diptheria Vaccine, by Type USD Million (2021-2026)
  • Table 379. China Diptheria Vaccine, by Disease Type USD Million (2021-2026)
  • Table 380. China Diptheria Vaccine, by Packaging Type USD Million (2021-2026)
  • Table 381. China Diptheria Vaccine, by Age Group USD Million (2021-2026)
  • Table 382. China Diptheria Vaccine, by End User USD Million (2021-2026)
  • Table 383. Japan Diptheria Vaccine, by Type USD Million (2021-2026)
  • Table 384. Japan Diptheria Vaccine, by Disease Type USD Million (2021-2026)
  • Table 385. Japan Diptheria Vaccine, by Packaging Type USD Million (2021-2026)
  • Table 386. Japan Diptheria Vaccine, by Age Group USD Million (2021-2026)
  • Table 387. Japan Diptheria Vaccine, by End User USD Million (2021-2026)
  • Table 388. India Diptheria Vaccine, by Type USD Million (2021-2026)
  • Table 389. India Diptheria Vaccine, by Disease Type USD Million (2021-2026)
  • Table 390. India Diptheria Vaccine, by Packaging Type USD Million (2021-2026)
  • Table 391. India Diptheria Vaccine, by Age Group USD Million (2021-2026)
  • Table 392. India Diptheria Vaccine, by End User USD Million (2021-2026)
  • Table 393. South Korea Diptheria Vaccine, by Type USD Million (2021-2026)
  • Table 394. South Korea Diptheria Vaccine, by Disease Type USD Million (2021-2026)
  • Table 395. South Korea Diptheria Vaccine, by Packaging Type USD Million (2021-2026)
  • Table 396. South Korea Diptheria Vaccine, by Age Group USD Million (2021-2026)
  • Table 397. South Korea Diptheria Vaccine, by End User USD Million (2021-2026)
  • Table 398. Taiwan Diptheria Vaccine, by Type USD Million (2021-2026)
  • Table 399. Taiwan Diptheria Vaccine, by Disease Type USD Million (2021-2026)
  • Table 400. Taiwan Diptheria Vaccine, by Packaging Type USD Million (2021-2026)
  • Table 401. Taiwan Diptheria Vaccine, by Age Group USD Million (2021-2026)
  • Table 402. Taiwan Diptheria Vaccine, by End User USD Million (2021-2026)
  • Table 403. Australia Diptheria Vaccine, by Type USD Million (2021-2026)
  • Table 404. Australia Diptheria Vaccine, by Disease Type USD Million (2021-2026)
  • Table 405. Australia Diptheria Vaccine, by Packaging Type USD Million (2021-2026)
  • Table 406. Australia Diptheria Vaccine, by Age Group USD Million (2021-2026)
  • Table 407. Australia Diptheria Vaccine, by End User USD Million (2021-2026)
  • Table 408. Rest of Asia-Pacific Diptheria Vaccine, by Type USD Million (2021-2026)
  • Table 409. Rest of Asia-Pacific Diptheria Vaccine, by Disease Type USD Million (2021-2026)
  • Table 410. Rest of Asia-Pacific Diptheria Vaccine, by Packaging Type USD Million (2021-2026)
  • Table 411. Rest of Asia-Pacific Diptheria Vaccine, by Age Group USD Million (2021-2026)
  • Table 412. Rest of Asia-Pacific Diptheria Vaccine, by End User USD Million (2021-2026)
  • Table 413. Europe Diptheria Vaccine, by Country USD Million (2021-2026)
  • Table 414. Europe Diptheria Vaccine, by Type USD Million (2021-2026)
  • Table 415. Europe Diptheria Vaccine, by Disease Type USD Million (2021-2026)
  • Table 416. Europe Diptheria Vaccine, by Packaging Type USD Million (2021-2026)
  • Table 417. Europe Diptheria Vaccine, by Age Group USD Million (2021-2026)
  • Table 418. Europe Diptheria Vaccine, by End User USD Million (2021-2026)
  • Table 419. Germany Diptheria Vaccine, by Type USD Million (2021-2026)
  • Table 420. Germany Diptheria Vaccine, by Disease Type USD Million (2021-2026)
  • Table 421. Germany Diptheria Vaccine, by Packaging Type USD Million (2021-2026)
  • Table 422. Germany Diptheria Vaccine, by Age Group USD Million (2021-2026)
  • Table 423. Germany Diptheria Vaccine, by End User USD Million (2021-2026)
  • Table 424. France Diptheria Vaccine, by Type USD Million (2021-2026)
  • Table 425. France Diptheria Vaccine, by Disease Type USD Million (2021-2026)
  • Table 426. France Diptheria Vaccine, by Packaging Type USD Million (2021-2026)
  • Table 427. France Diptheria Vaccine, by Age Group USD Million (2021-2026)
  • Table 428. France Diptheria Vaccine, by End User USD Million (2021-2026)
  • Table 429. Italy Diptheria Vaccine, by Type USD Million (2021-2026)
  • Table 430. Italy Diptheria Vaccine, by Disease Type USD Million (2021-2026)
  • Table 431. Italy Diptheria Vaccine, by Packaging Type USD Million (2021-2026)
  • Table 432. Italy Diptheria Vaccine, by Age Group USD Million (2021-2026)
  • Table 433. Italy Diptheria Vaccine, by End User USD Million (2021-2026)
  • Table 434. United Kingdom Diptheria Vaccine, by Type USD Million (2021-2026)
  • Table 435. United Kingdom Diptheria Vaccine, by Disease Type USD Million (2021-2026)
  • Table 436. United Kingdom Diptheria Vaccine, by Packaging Type USD Million (2021-2026)
  • Table 437. United Kingdom Diptheria Vaccine, by Age Group USD Million (2021-2026)
  • Table 438. United Kingdom Diptheria Vaccine, by End User USD Million (2021-2026)
  • Table 439. Netherlands Diptheria Vaccine, by Type USD Million (2021-2026)
  • Table 440. Netherlands Diptheria Vaccine, by Disease Type USD Million (2021-2026)
  • Table 441. Netherlands Diptheria Vaccine, by Packaging Type USD Million (2021-2026)
  • Table 442. Netherlands Diptheria Vaccine, by Age Group USD Million (2021-2026)
  • Table 443. Netherlands Diptheria Vaccine, by End User USD Million (2021-2026)
  • Table 444. Rest of Europe Diptheria Vaccine, by Type USD Million (2021-2026)
  • Table 445. Rest of Europe Diptheria Vaccine, by Disease Type USD Million (2021-2026)
  • Table 446. Rest of Europe Diptheria Vaccine, by Packaging Type USD Million (2021-2026)
  • Table 447. Rest of Europe Diptheria Vaccine, by Age Group USD Million (2021-2026)
  • Table 448. Rest of Europe Diptheria Vaccine, by End User USD Million (2021-2026)
  • Table 449. MEA Diptheria Vaccine, by Country USD Million (2021-2026)
  • Table 450. MEA Diptheria Vaccine, by Type USD Million (2021-2026)
  • Table 451. MEA Diptheria Vaccine, by Disease Type USD Million (2021-2026)
  • Table 452. MEA Diptheria Vaccine, by Packaging Type USD Million (2021-2026)
  • Table 453. MEA Diptheria Vaccine, by Age Group USD Million (2021-2026)
  • Table 454. MEA Diptheria Vaccine, by End User USD Million (2021-2026)
  • Table 455. Middle East Diptheria Vaccine, by Type USD Million (2021-2026)
  • Table 456. Middle East Diptheria Vaccine, by Disease Type USD Million (2021-2026)
  • Table 457. Middle East Diptheria Vaccine, by Packaging Type USD Million (2021-2026)
  • Table 458. Middle East Diptheria Vaccine, by Age Group USD Million (2021-2026)
  • Table 459. Middle East Diptheria Vaccine, by End User USD Million (2021-2026)
  • Table 460. Africa Diptheria Vaccine, by Type USD Million (2021-2026)
  • Table 461. Africa Diptheria Vaccine, by Disease Type USD Million (2021-2026)
  • Table 462. Africa Diptheria Vaccine, by Packaging Type USD Million (2021-2026)
  • Table 463. Africa Diptheria Vaccine, by Age Group USD Million (2021-2026)
  • Table 464. Africa Diptheria Vaccine, by End User USD Million (2021-2026)
  • Table 465. North America Diptheria Vaccine, by Country USD Million (2021-2026)
  • Table 466. North America Diptheria Vaccine, by Type USD Million (2021-2026)
  • Table 467. North America Diptheria Vaccine, by Disease Type USD Million (2021-2026)
  • Table 468. North America Diptheria Vaccine, by Packaging Type USD Million (2021-2026)
  • Table 469. North America Diptheria Vaccine, by Age Group USD Million (2021-2026)
  • Table 470. North America Diptheria Vaccine, by End User USD Million (2021-2026)
  • Table 471. United States Diptheria Vaccine, by Type USD Million (2021-2026)
  • Table 472. United States Diptheria Vaccine, by Disease Type USD Million (2021-2026)
  • Table 473. United States Diptheria Vaccine, by Packaging Type USD Million (2021-2026)
  • Table 474. United States Diptheria Vaccine, by Age Group USD Million (2021-2026)
  • Table 475. United States Diptheria Vaccine, by End User USD Million (2021-2026)
  • Table 476. Canada Diptheria Vaccine, by Type USD Million (2021-2026)
  • Table 477. Canada Diptheria Vaccine, by Disease Type USD Million (2021-2026)
  • Table 478. Canada Diptheria Vaccine, by Packaging Type USD Million (2021-2026)
  • Table 479. Canada Diptheria Vaccine, by Age Group USD Million (2021-2026)
  • Table 480. Canada Diptheria Vaccine, by End User USD Million (2021-2026)
  • Table 481. Mexico Diptheria Vaccine, by Type USD Million (2021-2026)
  • Table 482. Mexico Diptheria Vaccine, by Disease Type USD Million (2021-2026)
  • Table 483. Mexico Diptheria Vaccine, by Packaging Type USD Million (2021-2026)
  • Table 484. Mexico Diptheria Vaccine, by Age Group USD Million (2021-2026)
  • Table 485. Mexico Diptheria Vaccine, by End User USD Million (2021-2026)
  • Table 486. Diptheria Vaccine Sales: by Type(Tonne)
  • Table 487. Diptheria Vaccine Sales Daptacel , by Region Tonne (2021-2026)
  • Table 488. Diptheria Vaccine Sales Infanrix , by Region Tonne (2021-2026)
  • Table 489. Diptheria Vaccine Sales Kinrix , by Region Tonne (2021-2026)
  • Table 490. Diptheria Vaccine Sales Pediarix , by Region Tonne (2021-2026)
  • Table 491. Diptheria Vaccine Sales Pentacel , by Region Tonne (2021-2026)
  • Table 492. Diptheria Vaccine Sales Quaracel , by Region Tonne (2021-2026)
  • Table 493. Diptheria Vaccine Sales: by Disease Type(Tonne)
  • Table 494. Diptheria Vaccine Sales Diphtheria , by Region Tonne (2021-2026)
  • Table 495. Diptheria Vaccine Sales Tetanus , by Region Tonne (2021-2026)
  • Table 496. Diptheria Vaccine Sales Pertussis , by Region Tonne (2021-2026)
  • Table 497. Diptheria Vaccine Sales: by Packaging Type(Tonne)
  • Table 498. Diptheria Vaccine Sales 0.5 ML , by Region Tonne (2021-2026)
  • Table 499. Diptheria Vaccine Sales 1 ML , by Region Tonne (2021-2026)
  • Table 500. Diptheria Vaccine Sales 2 ML , by Region Tonne (2021-2026)
  • Table 501. Diptheria Vaccine Sales Others , by Region Tonne (2021-2026)
  • Table 502. Diptheria Vaccine Sales: by Age Group(Tonne)
  • Table 503. Diptheria Vaccine Sales Adult , by Region Tonne (2021-2026)
  • Table 504. Diptheria Vaccine Sales Pediatric , by Region Tonne (2021-2026)
  • Table 505. Diptheria Vaccine Sales: by End User(Tonne)
  • Table 506. Diptheria Vaccine Sales Hospitals , by Region Tonne (2021-2026)
  • Table 507. Diptheria Vaccine Sales Clinics , by Region Tonne (2021-2026)
  • Table 508. Diptheria Vaccine Sales Vaccination Centers , by Region Tonne (2021-2026)
  • Table 509. South America Diptheria Vaccine Sales, by Country Tonne (2021-2026)
  • Table 510. South America Diptheria Vaccine Sales, by Type Tonne (2021-2026)
  • Table 511. South America Diptheria Vaccine Sales, by Disease Type Tonne (2021-2026)
  • Table 512. South America Diptheria Vaccine Sales, by Packaging Type Tonne (2021-2026)
  • Table 513. South America Diptheria Vaccine Sales, by Age Group Tonne (2021-2026)
  • Table 514. South America Diptheria Vaccine Sales, by End User Tonne (2021-2026)
  • Table 515. Brazil Diptheria Vaccine Sales, by Type Tonne (2021-2026)
  • Table 516. Brazil Diptheria Vaccine Sales, by Disease Type Tonne (2021-2026)
  • Table 517. Brazil Diptheria Vaccine Sales, by Packaging Type Tonne (2021-2026)
  • Table 518. Brazil Diptheria Vaccine Sales, by Age Group Tonne (2021-2026)
  • Table 519. Brazil Diptheria Vaccine Sales, by End User Tonne (2021-2026)
  • Table 520. Argentina Diptheria Vaccine Sales, by Type Tonne (2021-2026)
  • Table 521. Argentina Diptheria Vaccine Sales, by Disease Type Tonne (2021-2026)
  • Table 522. Argentina Diptheria Vaccine Sales, by Packaging Type Tonne (2021-2026)
  • Table 523. Argentina Diptheria Vaccine Sales, by Age Group Tonne (2021-2026)
  • Table 524. Argentina Diptheria Vaccine Sales, by End User Tonne (2021-2026)
  • Table 525. Rest of South America Diptheria Vaccine Sales, by Type Tonne (2021-2026)
  • Table 526. Rest of South America Diptheria Vaccine Sales, by Disease Type Tonne (2021-2026)
  • Table 527. Rest of South America Diptheria Vaccine Sales, by Packaging Type Tonne (2021-2026)
  • Table 528. Rest of South America Diptheria Vaccine Sales, by Age Group Tonne (2021-2026)
  • Table 529. Rest of South America Diptheria Vaccine Sales, by End User Tonne (2021-2026)
  • Table 530. Asia Pacific Diptheria Vaccine Sales, by Country Tonne (2021-2026)
  • Table 531. Asia Pacific Diptheria Vaccine Sales, by Type Tonne (2021-2026)
  • Table 532. Asia Pacific Diptheria Vaccine Sales, by Disease Type Tonne (2021-2026)
  • Table 533. Asia Pacific Diptheria Vaccine Sales, by Packaging Type Tonne (2021-2026)
  • Table 534. Asia Pacific Diptheria Vaccine Sales, by Age Group Tonne (2021-2026)
  • Table 535. Asia Pacific Diptheria Vaccine Sales, by End User Tonne (2021-2026)
  • Table 536. China Diptheria Vaccine Sales, by Type Tonne (2021-2026)
  • Table 537. China Diptheria Vaccine Sales, by Disease Type Tonne (2021-2026)
  • Table 538. China Diptheria Vaccine Sales, by Packaging Type Tonne (2021-2026)
  • Table 539. China Diptheria Vaccine Sales, by Age Group Tonne (2021-2026)
  • Table 540. China Diptheria Vaccine Sales, by End User Tonne (2021-2026)
  • Table 541. Japan Diptheria Vaccine Sales, by Type Tonne (2021-2026)
  • Table 542. Japan Diptheria Vaccine Sales, by Disease Type Tonne (2021-2026)
  • Table 543. Japan Diptheria Vaccine Sales, by Packaging Type Tonne (2021-2026)
  • Table 544. Japan Diptheria Vaccine Sales, by Age Group Tonne (2021-2026)
  • Table 545. Japan Diptheria Vaccine Sales, by End User Tonne (2021-2026)
  • Table 546. India Diptheria Vaccine Sales, by Type Tonne (2021-2026)
  • Table 547. India Diptheria Vaccine Sales, by Disease Type Tonne (2021-2026)
  • Table 548. India Diptheria Vaccine Sales, by Packaging Type Tonne (2021-2026)
  • Table 549. India Diptheria Vaccine Sales, by Age Group Tonne (2021-2026)
  • Table 550. India Diptheria Vaccine Sales, by End User Tonne (2021-2026)
  • Table 551. South Korea Diptheria Vaccine Sales, by Type Tonne (2021-2026)
  • Table 552. South Korea Diptheria Vaccine Sales, by Disease Type Tonne (2021-2026)
  • Table 553. South Korea Diptheria Vaccine Sales, by Packaging Type Tonne (2021-2026)
  • Table 554. South Korea Diptheria Vaccine Sales, by Age Group Tonne (2021-2026)
  • Table 555. South Korea Diptheria Vaccine Sales, by End User Tonne (2021-2026)
  • Table 556. Taiwan Diptheria Vaccine Sales, by Type Tonne (2021-2026)
  • Table 557. Taiwan Diptheria Vaccine Sales, by Disease Type Tonne (2021-2026)
  • Table 558. Taiwan Diptheria Vaccine Sales, by Packaging Type Tonne (2021-2026)
  • Table 559. Taiwan Diptheria Vaccine Sales, by Age Group Tonne (2021-2026)
  • Table 560. Taiwan Diptheria Vaccine Sales, by End User Tonne (2021-2026)
  • Table 561. Australia Diptheria Vaccine Sales, by Type Tonne (2021-2026)
  • Table 562. Australia Diptheria Vaccine Sales, by Disease Type Tonne (2021-2026)
  • Table 563. Australia Diptheria Vaccine Sales, by Packaging Type Tonne (2021-2026)
  • Table 564. Australia Diptheria Vaccine Sales, by Age Group Tonne (2021-2026)
  • Table 565. Australia Diptheria Vaccine Sales, by End User Tonne (2021-2026)
  • Table 566. Rest of Asia-Pacific Diptheria Vaccine Sales, by Type Tonne (2021-2026)
  • Table 567. Rest of Asia-Pacific Diptheria Vaccine Sales, by Disease Type Tonne (2021-2026)
  • Table 568. Rest of Asia-Pacific Diptheria Vaccine Sales, by Packaging Type Tonne (2021-2026)
  • Table 569. Rest of Asia-Pacific Diptheria Vaccine Sales, by Age Group Tonne (2021-2026)
  • Table 570. Rest of Asia-Pacific Diptheria Vaccine Sales, by End User Tonne (2021-2026)
  • Table 571. Europe Diptheria Vaccine Sales, by Country Tonne (2021-2026)
  • Table 572. Europe Diptheria Vaccine Sales, by Type Tonne (2021-2026)
  • Table 573. Europe Diptheria Vaccine Sales, by Disease Type Tonne (2021-2026)
  • Table 574. Europe Diptheria Vaccine Sales, by Packaging Type Tonne (2021-2026)
  • Table 575. Europe Diptheria Vaccine Sales, by Age Group Tonne (2021-2026)
  • Table 576. Europe Diptheria Vaccine Sales, by End User Tonne (2021-2026)
  • Table 577. Germany Diptheria Vaccine Sales, by Type Tonne (2021-2026)
  • Table 578. Germany Diptheria Vaccine Sales, by Disease Type Tonne (2021-2026)
  • Table 579. Germany Diptheria Vaccine Sales, by Packaging Type Tonne (2021-2026)
  • Table 580. Germany Diptheria Vaccine Sales, by Age Group Tonne (2021-2026)
  • Table 581. Germany Diptheria Vaccine Sales, by End User Tonne (2021-2026)
  • Table 582. France Diptheria Vaccine Sales, by Type Tonne (2021-2026)
  • Table 583. France Diptheria Vaccine Sales, by Disease Type Tonne (2021-2026)
  • Table 584. France Diptheria Vaccine Sales, by Packaging Type Tonne (2021-2026)
  • Table 585. France Diptheria Vaccine Sales, by Age Group Tonne (2021-2026)
  • Table 586. France Diptheria Vaccine Sales, by End User Tonne (2021-2026)
  • Table 587. Italy Diptheria Vaccine Sales, by Type Tonne (2021-2026)
  • Table 588. Italy Diptheria Vaccine Sales, by Disease Type Tonne (2021-2026)
  • Table 589. Italy Diptheria Vaccine Sales, by Packaging Type Tonne (2021-2026)
  • Table 590. Italy Diptheria Vaccine Sales, by Age Group Tonne (2021-2026)
  • Table 591. Italy Diptheria Vaccine Sales, by End User Tonne (2021-2026)
  • Table 592. United Kingdom Diptheria Vaccine Sales, by Type Tonne (2021-2026)
  • Table 593. United Kingdom Diptheria Vaccine Sales, by Disease Type Tonne (2021-2026)
  • Table 594. United Kingdom Diptheria Vaccine Sales, by Packaging Type Tonne (2021-2026)
  • Table 595. United Kingdom Diptheria Vaccine Sales, by Age Group Tonne (2021-2026)
  • Table 596. United Kingdom Diptheria Vaccine Sales, by End User Tonne (2021-2026)
  • Table 597. Netherlands Diptheria Vaccine Sales, by Type Tonne (2021-2026)
  • Table 598. Netherlands Diptheria Vaccine Sales, by Disease Type Tonne (2021-2026)
  • Table 599. Netherlands Diptheria Vaccine Sales, by Packaging Type Tonne (2021-2026)
  • Table 600. Netherlands Diptheria Vaccine Sales, by Age Group Tonne (2021-2026)
  • Table 601. Netherlands Diptheria Vaccine Sales, by End User Tonne (2021-2026)
  • Table 602. Rest of Europe Diptheria Vaccine Sales, by Type Tonne (2021-2026)
  • Table 603. Rest of Europe Diptheria Vaccine Sales, by Disease Type Tonne (2021-2026)
  • Table 604. Rest of Europe Diptheria Vaccine Sales, by Packaging Type Tonne (2021-2026)
  • Table 605. Rest of Europe Diptheria Vaccine Sales, by Age Group Tonne (2021-2026)
  • Table 606. Rest of Europe Diptheria Vaccine Sales, by End User Tonne (2021-2026)
  • Table 607. MEA Diptheria Vaccine Sales, by Country Tonne (2021-2026)
  • Table 608. MEA Diptheria Vaccine Sales, by Type Tonne (2021-2026)
  • Table 609. MEA Diptheria Vaccine Sales, by Disease Type Tonne (2021-2026)
  • Table 610. MEA Diptheria Vaccine Sales, by Packaging Type Tonne (2021-2026)
  • Table 611. MEA Diptheria Vaccine Sales, by Age Group Tonne (2021-2026)
  • Table 612. MEA Diptheria Vaccine Sales, by End User Tonne (2021-2026)
  • Table 613. Middle East Diptheria Vaccine Sales, by Type Tonne (2021-2026)
  • Table 614. Middle East Diptheria Vaccine Sales, by Disease Type Tonne (2021-2026)
  • Table 615. Middle East Diptheria Vaccine Sales, by Packaging Type Tonne (2021-2026)
  • Table 616. Middle East Diptheria Vaccine Sales, by Age Group Tonne (2021-2026)
  • Table 617. Middle East Diptheria Vaccine Sales, by End User Tonne (2021-2026)
  • Table 618. Africa Diptheria Vaccine Sales, by Type Tonne (2021-2026)
  • Table 619. Africa Diptheria Vaccine Sales, by Disease Type Tonne (2021-2026)
  • Table 620. Africa Diptheria Vaccine Sales, by Packaging Type Tonne (2021-2026)
  • Table 621. Africa Diptheria Vaccine Sales, by Age Group Tonne (2021-2026)
  • Table 622. Africa Diptheria Vaccine Sales, by End User Tonne (2021-2026)
  • Table 623. North America Diptheria Vaccine Sales, by Country Tonne (2021-2026)
  • Table 624. North America Diptheria Vaccine Sales, by Type Tonne (2021-2026)
  • Table 625. North America Diptheria Vaccine Sales, by Disease Type Tonne (2021-2026)
  • Table 626. North America Diptheria Vaccine Sales, by Packaging Type Tonne (2021-2026)
  • Table 627. North America Diptheria Vaccine Sales, by Age Group Tonne (2021-2026)
  • Table 628. North America Diptheria Vaccine Sales, by End User Tonne (2021-2026)
  • Table 629. United States Diptheria Vaccine Sales, by Type Tonne (2021-2026)
  • Table 630. United States Diptheria Vaccine Sales, by Disease Type Tonne (2021-2026)
  • Table 631. United States Diptheria Vaccine Sales, by Packaging Type Tonne (2021-2026)
  • Table 632. United States Diptheria Vaccine Sales, by Age Group Tonne (2021-2026)
  • Table 633. United States Diptheria Vaccine Sales, by End User Tonne (2021-2026)
  • Table 634. Canada Diptheria Vaccine Sales, by Type Tonne (2021-2026)
  • Table 635. Canada Diptheria Vaccine Sales, by Disease Type Tonne (2021-2026)
  • Table 636. Canada Diptheria Vaccine Sales, by Packaging Type Tonne (2021-2026)
  • Table 637. Canada Diptheria Vaccine Sales, by Age Group Tonne (2021-2026)
  • Table 638. Canada Diptheria Vaccine Sales, by End User Tonne (2021-2026)
  • Table 639. Mexico Diptheria Vaccine Sales, by Type Tonne (2021-2026)
  • Table 640. Mexico Diptheria Vaccine Sales, by Disease Type Tonne (2021-2026)
  • Table 641. Mexico Diptheria Vaccine Sales, by Packaging Type Tonne (2021-2026)
  • Table 642. Mexico Diptheria Vaccine Sales, by Age Group Tonne (2021-2026)
  • Table 643. Mexico Diptheria Vaccine Sales, by End User Tonne (2021-2026)
  • Table 644. Diptheria Vaccine: by Type(USD/Units)
  • Table 645. Research Programs/Design for This Report
  • Table 646. Key Data Information from Secondary Sources
  • Table 647. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Diptheria Vaccine: by Type USD Million (2015-2020)
  • Figure 5. Global Diptheria Vaccine: by Disease Type USD Million (2015-2020)
  • Figure 6. Global Diptheria Vaccine: by Packaging Type USD Million (2015-2020)
  • Figure 7. Global Diptheria Vaccine: by Age Group USD Million (2015-2020)
  • Figure 8. Global Diptheria Vaccine: by End User USD Million (2015-2020)
  • Figure 9. South America Diptheria Vaccine Share (%), by Country
  • Figure 10. Asia Pacific Diptheria Vaccine Share (%), by Country
  • Figure 11. Europe Diptheria Vaccine Share (%), by Country
  • Figure 12. MEA Diptheria Vaccine Share (%), by Country
  • Figure 13. North America Diptheria Vaccine Share (%), by Country
  • Figure 14. Global Diptheria Vaccine: by Type Tonne (2015-2020)
  • Figure 15. Global Diptheria Vaccine: by Disease Type Tonne (2015-2020)
  • Figure 16. Global Diptheria Vaccine: by Packaging Type Tonne (2015-2020)
  • Figure 17. Global Diptheria Vaccine: by Age Group Tonne (2015-2020)
  • Figure 18. Global Diptheria Vaccine: by End User Tonne (2015-2020)
  • Figure 19. South America Diptheria Vaccine Share (%), by Country
  • Figure 20. Asia Pacific Diptheria Vaccine Share (%), by Country
  • Figure 21. Europe Diptheria Vaccine Share (%), by Country
  • Figure 22. MEA Diptheria Vaccine Share (%), by Country
  • Figure 23. North America Diptheria Vaccine Share (%), by Country
  • Figure 24. Global Diptheria Vaccine: by Type USD/Units (2015-2020)
  • Figure 25. Global Diptheria Vaccine share by Players 2020 (%)
  • Figure 26. Global Diptheria Vaccine share by Players (Top 3) 2020(%)
  • Figure 27. Global Diptheria Vaccine share by Players (Top 5) 2020(%)
  • Figure 28. BCG Matrix for key Companies
  • Figure 29. GlaxoSmithKline plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. GlaxoSmithKline plc (United Kingdom) Revenue: by Geography 2020
  • Figure 31. Sanofi Pasteur (France) Revenue, Net Income and Gross profit
  • Figure 32. Sanofi Pasteur (France) Revenue: by Geography 2020
  • Figure 33. Protein Sciences Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 34. Protein Sciences Corporation (United States) Revenue: by Geography 2020
  • Figure 35. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 36. Novartis AG (Switzerland) Revenue: by Geography 2020
  • Figure 37. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 38. Merck & Co., Inc. (United States) Revenue: by Geography 2020
  • Figure 39. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. Pfizer Inc. (United States) Revenue: by Geography 2020
  • Figure 41. Astellas Pharma Inc. (Japan) Revenue, Net Income and Gross profit
  • Figure 42. Astellas Pharma Inc. (Japan) Revenue: by Geography 2020
  • Figure 43. AstraZeneca (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 44. AstraZeneca (United Kingdom) Revenue: by Geography 2020
  • Figure 45. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 46. Johnson & Johnson (United States) Revenue: by Geography 2020
  • Figure 47. Emergent Biosolution Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 48. Emergent Biosolution Inc. (United States) Revenue: by Geography 2020
  • Figure 49. Global Diptheria Vaccine: by Type USD Million (2021-2026)
  • Figure 50. Global Diptheria Vaccine: by Disease Type USD Million (2021-2026)
  • Figure 51. Global Diptheria Vaccine: by Packaging Type USD Million (2021-2026)
  • Figure 52. Global Diptheria Vaccine: by Age Group USD Million (2021-2026)
  • Figure 53. Global Diptheria Vaccine: by End User USD Million (2021-2026)
  • Figure 54. South America Diptheria Vaccine Share (%), by Country
  • Figure 55. Asia Pacific Diptheria Vaccine Share (%), by Country
  • Figure 56. Europe Diptheria Vaccine Share (%), by Country
  • Figure 57. MEA Diptheria Vaccine Share (%), by Country
  • Figure 58. North America Diptheria Vaccine Share (%), by Country
  • Figure 59. Global Diptheria Vaccine: by Type Tonne (2021-2026)
  • Figure 60. Global Diptheria Vaccine: by Disease Type Tonne (2021-2026)
  • Figure 61. Global Diptheria Vaccine: by Packaging Type Tonne (2021-2026)
  • Figure 62. Global Diptheria Vaccine: by Age Group Tonne (2021-2026)
  • Figure 63. Global Diptheria Vaccine: by End User Tonne (2021-2026)
  • Figure 64. South America Diptheria Vaccine Share (%), by Country
  • Figure 65. Asia Pacific Diptheria Vaccine Share (%), by Country
  • Figure 66. Europe Diptheria Vaccine Share (%), by Country
  • Figure 67. MEA Diptheria Vaccine Share (%), by Country
  • Figure 68. North America Diptheria Vaccine Share (%), by Country
  • Figure 69. Global Diptheria Vaccine: by Type USD/Units (2021-2026)
Some of the key companies/manufacturers profiled in the report
  • GlaxoSmithKline plc (United Kingdom)
  • Sanofi Pasteur (France)
  • Protein Sciences Corporation (United States)
  • Novartis AG (Switzerland)
  • Merck & Co., Inc. (United States)
  • Pfizer Inc. (United States)
  • Astellas Pharma Inc. (Japan)
  • AstraZeneca (United Kingdom)
  • Johnson & Johnson (United States)
  • Emergent Biosolution Inc. (United States)
Additional players considered in the study are as follows:
AJ Vaccines (Denmark) , Bionet-Asia (Thailand) , Massbiologics (United States) , KM biologics co., Ltd. (Japan) , Panacea Biotec Ltd. (India) , Serum Institute of India Pvt. Ltd. (India)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation